Targeting plasmid-encoded proteins to the antigen presentation pathways
- PMID: 15233725
- DOI: 10.1111/j.0105-2896.2004.0135.x
Targeting plasmid-encoded proteins to the antigen presentation pathways
Abstract
The antigen presentation pathways constitute a fulcrum on which adaptive immunity is balanced, and their manipulation should allow us to induce designer immune responses. The ease and rapidity with which DNA vaccines can be constructed and altered make them ideal candidates with which to test the various targeting strategies that have been conceived to date. These approaches and the mechanisms that may (or may not) underlie their success are reviewed in this article.
Similar articles
-
[Mechanism of priming cytotoxic T cell response and strategy for enhancing DNA vaccine potency in DNA immunization].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2003 Mar;20(1):175-9. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2003. PMID: 12744193 Review. Chinese.
-
Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.Immunol Lett. 2007 Aug 15;111(2):92-102. doi: 10.1016/j.imlet.2007.05.007. Epub 2007 Jun 18. Immunol Lett. 2007. PMID: 17604849
-
Cross-presentation: underlying mechanisms and role in immune surveillance.Immunol Rev. 2005 Oct;207:166-83. doi: 10.1111/j.0105-2896.2005.00301.x. Immunol Rev. 2005. PMID: 16181335 Review.
-
Improving DNA vaccine potency via modification of professional antigen presenting cells.Curr Opin Mol Ther. 2003 Feb;5(1):20-4. Curr Opin Mol Ther. 2003. PMID: 12669466 Review.
-
Priming of CTL responses by DNA vaccines: direct transfection of antigen presenting cells versus cross-priming.Dev Biol (Basel). 2000;104:9-14. Dev Biol (Basel). 2000. PMID: 11713829 Review.
Cited by
-
Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers.Nanomedicine (Lond). 2015 Jul;10(12):1923-40. doi: 10.2217/nnm.15.39. Nanomedicine (Lond). 2015. PMID: 26139126 Free PMC article. Review.
-
Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo.Hum Gene Ther. 2009 Oct;20(10):1143-56. doi: 10.1089/hum.2009.025. Hum Gene Ther. 2009. PMID: 19530914 Free PMC article.
-
Regulation of Immunogen Processing: Signal Sequences and Their Application for the New Generation of DNA-Vaccines.Acta Naturae. 2010 Apr;2(1):53-60. Acta Naturae. 2010. PMID: 22649628 Free PMC article.
-
The amino acid sequences flanking an antigenic determinant can strongly affect MHC class I cross-presentation without altering direct presentation.J Immunol. 2009 Apr 15;182(8):4601-7. doi: 10.4049/jimmunol.0803806. J Immunol. 2009. PMID: 19342634 Free PMC article.
-
DC-based cancer vaccines.J Clin Invest. 2007 May;117(5):1195-203. doi: 10.1172/JCI31205. J Clin Invest. 2007. PMID: 17476349 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources